Takeda Pharmaceutical Co., Ltd. (TAK)
15.72
-0.02
(-0.16%)
USD |
NYSE |
Jun 09, 16:00
15.72
0.00 (0.00%)
After-Hours: 17:45
Takeda Pharmaceutical EPS Diluted (Quarterly) : -0.0496 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Novartis AG | 1.654 |
| Johnson & Johnson | 2.141 |
| Eli Lilly & Co. | 8.255 |
| Pfizer Inc. | 0.4688 |
| Sanofi | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -154.60M |
| Revenue (Quarterly) | 6.976B |
| Total Expenses (Quarterly) | 7.131B |
| Enterprise Value | 76.69B |
| Gross Profit Margin (Quarterly) | 48.79% |
| Profit Margin (Quarterly) | -2.22% |
| Earnings Yield | 2.58% |
| Operating Earnings Yield | 7.25% |